210 related articles for article (PubMed ID: 30545440)
21. MiR-424-5p participates in esophageal squamous cell carcinoma invasion and metastasis via SMAD7 pathway mediated EMT.
Wang F; Wang J; Yang X; Chen D; Wang L
Diagn Pathol; 2016 Sep; 11(1):88. PubMed ID: 27628042
[TBL] [Abstract][Full Text] [Related]
22. CircPTK2/PABPC1/SETDB1 axis promotes EMT-mediated tumor metastasis and gemcitabine resistance in bladder cancer.
Meng X; Xiao W; Sun J; Li W; Yuan H; Yu T; Zhang X; Dong W
Cancer Lett; 2023 Feb; 554():216023. PubMed ID: 36436682
[TBL] [Abstract][Full Text] [Related]
23. MiR-7, inhibited indirectly by lincRNA HOTAIR, directly inhibits SETDB1 and reverses the EMT of breast cancer stem cells by downregulating the STAT3 pathway.
Zhang H; Cai K; Wang J; Wang X; Cheng K; Shi F; Jiang L; Zhang Y; Dou J
Stem Cells; 2014 Nov; 32(11):2858-68. PubMed ID: 25070049
[TBL] [Abstract][Full Text] [Related]
24. SETDB1 promotes progression through upregulation of SF3B4 expression and regulates the immunity in ovarian cancer.
Yang H; Sui L; Cai C; Chu H; Diao Y
J Ovarian Res; 2024 Feb; 17(1):34. PubMed ID: 38317200
[TBL] [Abstract][Full Text] [Related]
25. Histone methyltransferase SETDB1 is required for prostate cancer cell proliferation, migration and invasion.
Sun Y; Wei M; Ren SC; Chen R; Xu WD; Wang FB; Lu J; Shen J; Yu YW; Hou JG; Xu CL; Huang JT; Sun YH
Asian J Androl; 2014; 16(2):319-24. PubMed ID: 24556744
[TBL] [Abstract][Full Text] [Related]
26. Regulation of Oral Squamous Cell Carcinoma Proliferation Through Crosstalk Between SMAD7 and CYLD.
Ge WL; Xu JF; Hu J
Cell Physiol Biochem; 2016; 38(3):1209-17. PubMed ID: 26982322
[TBL] [Abstract][Full Text] [Related]
27. In silico probing and biological evaluation of SETDB1/ESET-targeted novel compounds that reduce tri-methylated histone H3K9 (H3K9me3) level.
Park I; Hwang YJ; Kim T; Viswanath ANI; Londhe AM; Jung SY; Sim KM; Min SJ; Lee JE; Seong J; Kim YK; No KT; Ryu H; Pae AN
J Comput Aided Mol Des; 2017 Oct; 31(10):877-889. PubMed ID: 28879500
[TBL] [Abstract][Full Text] [Related]
28. Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis.
Rodriguez-Paredes M; Martinez de Paz A; Simó-Riudalbas L; Sayols S; Moutinho C; Moran S; Villanueva A; Vázquez-Cedeira M; Lazo PA; Carneiro F; Moura CS; Vieira J; Teixeira MR; Esteller M
Oncogene; 2014 May; 33(21):2807-13. PubMed ID: 23770855
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cells.
Yu J; Lei R; Zhuang X; Li X; Li G; Lev S; Segura MF; Zhang X; Hu G
Nat Commun; 2016 Dec; 7():13884. PubMed ID: 27996004
[TBL] [Abstract][Full Text] [Related]
30. Histone Methyltransferase hSETD1A Is a Novel Regulator of Metastasis in Breast Cancer.
Salz T; Deng C; Pampo C; Siemann D; Qiu Y; Brown K; Huang S
Mol Cancer Res; 2015 Mar; 13(3):461-9. PubMed ID: 25373480
[TBL] [Abstract][Full Text] [Related]
31. Akt/PKB interacts with the histone H3 methyltransferase SETDB1 and coordinates to silence gene expression.
Gao H; Yu Z; Bi D; Jiang L; Cui Y; Sun J; Ma R
Mol Cell Biochem; 2007 Nov; 305(1-2):35-44. PubMed ID: 17577629
[TBL] [Abstract][Full Text] [Related]
32. MiR-181c modulates the proliferation, migration, and invasion of neuroblastoma cells by targeting Smad7.
Li Y; Wang H; Li J; Yue W
Acta Biochim Biophys Sin (Shanghai); 2014 Jan; 46(1):48-55. PubMed ID: 24345480
[TBL] [Abstract][Full Text] [Related]
33. SETDB1-mediated FosB regulation via ERK2 is associated with an increase in cell invasiveness during anticancer drug treatment of A549 human lung cancer cells.
Na HH; Kim KC
Biochem Biophys Res Commun; 2018 Jan; 495(1):512-518. PubMed ID: 29108991
[TBL] [Abstract][Full Text] [Related]
34. Emerging role of SETDB1 as a therapeutic target.
Karanth AV; Maniswami RR; Prashanth S; Govindaraj H; Padmavathy R; Jegatheesan SK; Mullangi R; Rajagopal S
Expert Opin Ther Targets; 2017 Mar; 21(3):319-331. PubMed ID: 28076698
[TBL] [Abstract][Full Text] [Related]
35. Blocking histone methyltransferase SETDB1 inhibits tumorigenesis and enhances cetuximab sensitivity in colorectal cancer.
Hou Z; Sun L; Xu F; Hu F; Lan J; Song D; Feng Y; Wang J; Luo X; Hu J; Wang G
Cancer Lett; 2020 Sep; 487():63-73. PubMed ID: 32473242
[TBL] [Abstract][Full Text] [Related]
36. DZNep, inhibitor of S-adenosylhomocysteine hydrolase, down-regulates expression of SETDB1 H3K9me3 HMTase in human lung cancer cells.
Lee JK; Kim KC
Biochem Biophys Res Commun; 2013 Sep; 438(4):647-52. PubMed ID: 23933322
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-21 induces breast cancer cell invasion and migration by suppressing smad7 via EGF and TGF-β pathways.
Han M; Wang F; Gu Y; Pei X; Guo G; Yu C; Li L; Zhu M; Xiong Y; Wang Y
Oncol Rep; 2016 Jan; 35(1):73-80. PubMed ID: 26531758
[TBL] [Abstract][Full Text] [Related]
38. SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins.
Schultz DC; Ayyanathan K; Negorev D; Maul GG; Rauscher FJ
Genes Dev; 2002 Apr; 16(8):919-32. PubMed ID: 11959841
[TBL] [Abstract][Full Text] [Related]
39. Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target.
Orouji E; Federico A; Larribère L; Novak D; Lipka DB; Assenov Y; Sachindra S; Hüser L; Granados K; Gebhardt C; Plass C; Umansky V; Utikal J
Int J Cancer; 2019 Dec; 145(12):3462-3477. PubMed ID: 31131878
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer metastasis suppressor OTUD1 deubiquitinates SMAD7.
Zhang Z; Fan Y; Xie F; Zhou H; Jin K; Shao L; Shi W; Fang P; Yang B; van Dam H; Ten Dijke P; Zheng X; Yan X; Jia J; Zheng M; Jin J; Ding C; Ye S; Zhou F; Zhang L
Nat Commun; 2017 Dec; 8(1):2116. PubMed ID: 29235476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
